Top Takeaways from ACC.26

In this week's View, Dr. Eagle highlights trials from the recently held ACC Scientific Sessions which took place in New Orleans, March 28-30. Important studies discussed include:

• CHAMPION-AF: Left atrial appendage closure vs. anticoagulation for AFib

• VESALIUS-CV: Evolocumab reduces CV risk in diabetic patients without ASCVD

• Ez-PAVE: Hitting lower LDL-C target reduces major CV events

• PRO-TAVI: Should high-risk patients undergo PCI before TAVI?

• SMART-DECISION: Discontinuing beta-blockers safe 1 year post MI For stable patients

• GoFreshRx: How home-delivered DASH groceries improve blood pressure (BP) and LDL-C

• THRIVE: Exploring the positive effects of a culturally tailored "food-is medicine" program on lowering BP